Speech-Language Pathologists in Calera, AL Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Mrs. Kristie Franks, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2134 Timberline Dr, Calera, AL 35040 Phone: 205-668-9984

Alana Flow, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10465 Highway 25, Calera, AL 35040 Phone: 205-706-0809

Sara Hamilton, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45 Southern Hills Dr, Calera, AL 35040 Phone: 205-907-7740

News Archive

SPARC protein acts much like ibuprofen to heal tissues inflamed by tumors

Cancer researchers are increasingly aware that in addition to genetic mutations in a cancer itself, characteristics of the surrounding tissue can promote or suppress tumor growth. One of these important tissue characteristics is inflammation - most cancers prosper in and attach to inflamed tissue and so many cancers have developed ways to create it.

p62 and ERK proteins lead to development of obesity and insulin resistance, say scientists

New research by University of Cincinnati scientists implicates a new protein in obesity development and highlights a protein pair's "team effort" in regulating obesity and insulin resistance.

Sleeping less than nine hours affects children's academic skills

A study by the Autonomous University of Barcelona (UAB in Spanish) and Ramón Llull University have researched the relationship between the sleeping habits, hours slept, and academic performance of children aged between six and seven years of age. Experts have found that sleeping less than nine hours, going to bed late and no bedtime routine generally affects children's academic skills.

Influenza vaccination should become a part of standard hospital care after myocardial infarction

Influenza vaccination reduces the risk of all-cause death, myocardial infarction, or stent thrombosis at 12 months in hospitalized patients with myocardial infarction or high-risk coronary disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2021.

Study looks at drug resistance in BRAF-mutated gliomas

Looking to understand why some brain tumors with a specific mutation can start to reject drugs commonly used to treat them, CU Cancer Center member Jean Mulcahy Levy, MD, led researchers from institutions around the country -; including several from the University of Colorado School of Medicine -; to study samples of brain tumors before and after being treated with the drug.

Read more Medical News

› Verified 8 days ago